Cargando…
Availability of New Medicines in the US and Germany From 2004 to 2018
IMPORTANCE: Germany’s unique approach to coverage determination and pricing has ensured that effective medicines remain on the market, often at prices reduced through negotiation. However, less is known about trade-offs of this approach with regard to initial availability of medicines. OBJECTIVE: To...
Autores principales: | Blankart, Katharina, Naci, Huseyin, Chandra, Amitabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428736/ https://www.ncbi.nlm.nih.gov/pubmed/36040738 http://dx.doi.org/10.1001/jamanetworkopen.2022.29231 |
Ejemplares similares
-
Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland
por: Carl, David L., et al.
Publicado: (2022) -
Evaluation of Temporal Trends in Racial and Ethnic Disparities in Sleep Duration Among US Adults, 2004-2018
por: Caraballo, César, et al.
Publicado: (2022) -
Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018
por: Nogueira, Leticia M., et al.
Publicado: (2022) -
Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018
por: Nogueira, Leticia M., et al.
Publicado: (2022) -
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)